These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26068527)

  • 1. Effect of fluvoxamine on the pharmacokinetics and pharmacodynamics of clopidogrel in rats.
    Chen F; Yang Y; Fang C; Zhao J; Han M; Zhu Q; Bai X; Liu M; Yang G
    Xenobiotica; 2015; 45(12):1122-8. PubMed ID: 26068527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential impact of selective serotonin reuptake inhibitors on platelet response to clopidogrel: a randomized, double-blind, crossover trial.
    Hirsh-Rokach B; Spectre G; Shai E; Lotan A; Ritter A; Al-Aieshy F; Malmström RE; Varon D; Alcalai R
    Pharmacotherapy; 2015 Feb; 35(2):140-7. PubMed ID: 25689244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of scutellarin on the metabolism and pharmacokinetics of clopidogrel in rats.
    Chen X; Jin J; Chen Y; Peng L; Zhong G; Li J; Bi H; Cai Y; Huang M
    Biopharm Drug Dispos; 2015 Jan; 36(1):64-8. PubMed ID: 25256597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin alters the pharmacokinetics of warfarin and clopidogrel in Wistar rats but has no effect on anticoagulation or antiplatelet aggregation.
    Liu AC; Zhao LX; Lou HX
    Planta Med; 2013 Jul; 79(11):971-7. PubMed ID: 23807811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and platelet aggregation inhibitory effects of a novel intravenous formulation of clopidogrel in humans.
    Cushing DJ; Souney PF; Cooper WD; Mosher GL; Adams MP; Machatha S; Zhang B; Kowey PR
    Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):3-8. PubMed ID: 21933229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of common ABCB1 polymorphism on pharmacokinetics and pharmacodynamics of clopidogrel and its metabolites.
    Karaźniewicz-Łada M; Danielak D; Rubiś B; Burchardt P; Komosa A; Lesiak M; Główka F
    J Clin Pharm Ther; 2015 Apr; 40(2):226-31. PubMed ID: 25430046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic and pharmacokinetic evaluation of clopidogrel and the carboxylic acid metabolite SR 26334 in healthy dogs.
    Brainard BM; Kleine SA; Papich MG; Budsberg SC
    Am J Vet Res; 2010 Jul; 71(7):822-30. PubMed ID: 20594086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects.
    Kim SD; Kang W; Lee HW; Park DJ; Ahn JH; Kim MJ; Kim EY; Kim SW; Nam HS; Na HJ; Yoon YR
    Clin Ther; 2009 Apr; 31(4):793-803. PubMed ID: 19446152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking behaviour modulates pharmacokinetics of orally administered clopidogrel.
    Yousef AM; Arafat T; Bulatova NR; Al-Zumyli R
    J Clin Pharm Ther; 2008 Aug; 33(4):439-49. PubMed ID: 18613862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased active metabolite formation explains the greater platelet inhibition with prasugrel compared to high-dose clopidogrel.
    Payne CD; Li YG; Small DS; Ernest CS; Farid NA; Jakubowski JA; Brandt JT; Salazar DE; Winters KJ
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):555-62. PubMed ID: 18030066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450 3A inhibition by ketoconazole affects prasugrel and clopidogrel pharmacokinetics and pharmacodynamics differently.
    Farid NA; Payne CD; Small DS; Winters KJ; Ernest CS; Brandt JT; Darstein C; Jakubowski JA; Salazar DE
    Clin Pharmacol Ther; 2007 May; 81(5):735-41. PubMed ID: 17361128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Danshen capsules on the pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers.
    Zhou CH; Xu M; Yu HB; Zheng XT; Zhong ZF; Zhang LT
    Food Chem Toxicol; 2018 Sep; 119():302-308. PubMed ID: 29496531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ranitidine on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel.
    Small DS; Farid NA; Li YG; Ernest CS; Payne CD; Salazar DE; Winters KJ
    Curr Med Res Opin; 2008 Aug; 24(8):2251-7. PubMed ID: 18786302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic understanding of the effect of Dengzhan Shengmai capsule on the pharmacokinetics of clopidogrel in rats.
    Chen X; Zhao Z; Chen Y; Gou X; Zhou Z; Zhong G; Cai Y; Huang M; Jin J
    J Ethnopharmacol; 2016 Nov; 192():362-369. PubMed ID: 27459888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel.
    Small DS; Farid NA; Payne CD; Weerakkody GJ; Li YG; Brandt JT; Salazar DE; Winters KJ
    J Clin Pharmacol; 2008 Apr; 48(4):475-84. PubMed ID: 18303127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacokinetics/pharmacodynamics of clopidogrel besylate and clopidogrel bisulfate in healthy Korean subjects.
    Kim BH; Kim JR; Lim KS; Shin HS; Yoon SH; Cho JY; Jang IJ; Shin SG; Yu KS
    Clin Drug Investig; 2012 Dec; 32(12):817-26. PubMed ID: 23026843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of clopidogrel.
    Caplain H; Donat F; Gaud C; Necciari J
    Semin Thromb Hemost; 1999; 25 Suppl 2():25-8. PubMed ID: 10440419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboxylesterase 1 c.428G>A single nucleotide variation increases the antiplatelet effects of clopidogrel by reducing its hydrolysis in humans.
    Tarkiainen EK; Holmberg MT; Tornio A; Neuvonen M; Neuvonen PJ; Backman JT; Niemi M
    Clin Pharmacol Ther; 2015 Jun; 97(6):650-8. PubMed ID: 25704243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases.
    Karaźniewicz-Łada M; Danielak D; Burchardt P; Kruszyna L; Komosa A; Lesiak M; Główka F
    Clin Pharmacokinet; 2014 Feb; 53(2):155-64. PubMed ID: 24127209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of clopidogrel on pharmacokinetics of ivabradine and its metabolite in rats.
    Sun W; Wang Z; Chen H; Zhang XD; Huang CK; Lian QQ; Shang-Guan WN; Zhu GH; Hu GX; Wang ZS
    Drug Dev Ind Pharm; 2015; 41(9):1512-7. PubMed ID: 25250618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.